Age‐adjusted comorbidity and survival in locally advanced laryngeal cancer

The purpose of this study was to quantify the relationship among age, pretreatment comorbidity, and survival outcomes in patients with locally advanced laryngeal cancer.

[1]  A. Garden,et al.  Long‐term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches , 2016, Head & neck.

[2]  J. Piccirillo.  Importance of comborbidity in head and neck cancer , 2015 .

[3]  A. Garden,et al.  Long‐term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3‐decade survey , 2015, Cancer.

[4]  H. Bahig,et al.  Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer. , 2015, Oral oncology.

[5]  Shih-Lun Chang,et al.  Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study , 2015, PloS one.

[6]  J. Roh,et al.  Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  L. Mell,et al.  Population-based study of competing mortality in head and neck cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Carricondo,et al.  The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma , 2011, Acta oto-laryngologica.

[9]  E. Vokes,et al.  Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy , 2004, Clinical Cancer Research.

[10]  V. Paleri,et al.  Impact of comorbidity on the outcome of laryngeal squamous cancer , 2003, Head & neck.

[11]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[12]  D. Roberts,et al.  The significance of comorbidity in advanced laryngeal cancer , 2001, Head & neck.

[13]  S. Hall,et al.  The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck , 2000, Head & neck.

[14]  R. Rosenfeld,et al.  The Impact of Comorbidity and Age on Survival with Laryngeal Cancer , 1999, Ear, nose, & throat journal.

[15]  R. Rosenfeld,et al.  Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional Study , 1997, The Laryngoscope.

[16]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[17]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[18]  N. Sakamoto,et al.  Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis , 2014, Annals of Surgical Oncology.

[19]  R. Weichselbaum,et al.  Predictors of competing mortality in advanced head and neck cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .

[21]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.